Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-May-24 5:03 PM View:  | Guardant Health, Inc. (GH) | 30-Apr-24 | Option Exercise | 154 | -- | -- | 5% 3.24K to 3.39K | |
| 02-Apr-24 6:07 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Apr-24 | Sale (Planned) | 92,500 | $20.50 | $1,896,250.00 | (9%) 989.84K to 897.34K | |
| 01-Apr-24 5:25 PM View: | Guardant Health, Inc. (GH) | 31-Mar-24 | Option Exercise | 154 | -- | -- | 5% 3.08K to 3.24K | |
| 01-Mar-24 5:08 PM View: | Guardant Health, Inc. (GH) | 29-Feb-24 | Option Exercise | 154 | -- | -- | 5% 2.93K to 3.08K | |
| 15-Feb-24 9:16 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-24 | Sale | 2,750 | $17.29 | $47,547.50 | (< 1%) 992.59K to 989.84K | |
| 01-Feb-24 5:38 PM View: | Guardant Health, Inc. (GH) | 31-Jan-24 | Option Exercise | 155 | -- | -- | 6% 2.78K to 2.93K | |
| 09-Jan-24 7:34 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-24 | Sale | 3,208 | $19.43 | $62,331.40 | (< 1%) 995.8K to 992.59K | |
| 02-Jan-24 6:06 PM View: | Guardant Health, Inc. (GH) | 31-Dec-23 | Option Exercise | 154 | -- | -- | 6% 2.62K to 2.78K | |
| 04-Dec-23 6:22 PM View: | Guardant Health, Inc. (GH) | 30-Nov-23 | Option Exercise | 154 | -- | -- | 6% 2.47K to 2.62K | |
| 01-Nov-23 8:07 PM View: | Guardant Health, Inc. (GH) | 31-Oct-23 | Option Exercise | 154 | -- | -- | 7% 2.31K to 2.47K | |
| 02-Oct-23 10:00 PM View: | Guardant Health, Inc. (GH) | 30-Sep-23 | Option Exercise | 155 | -- | -- | 7% 2.16K to 2.31K | |
| 05-Sep-23 4:46 PM View: | Guardant Health, Inc. (GH) | 31-Aug-23 | Option Exercise | 154 | -- | -- | 8% 2.0K to 2.16K | |
| 23-Aug-23 4:31 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Aug-23 | Sale | 1,419 | $22.60 | $32,069.40 | (< 1%) 997.22K to 995.8K | |
| 01-Aug-23 6:08 PM View: | Guardant Health, Inc. (GH) | 31-Jul-23 | Option Exercise | 154 | -- | -- | 8% 1.85K to 2.0K | |
| 05-Jul-23 4:59 PM View: | Guardant Health, Inc. (GH) | 30-Jun-23 | Option Exercise | 1,851 | -- | -- | 100% 0 to 1.85K | |
| 05-Jun-23 6:07 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Jun-23 | Grant | 4,216 | -- | -- | < 1% 993.0K to 997.22K | |
| 15-Feb-23 7:02 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-23 | Sale | 2,119 | $30.10 | $63,781.90 | (< 1%) 995.12K to 993.0K | |
| 10-Feb-23 6:10 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Feb-23 | Sale | 1,377 | $30.88 | $42,521.80 | (< 1%) 996.5K to 995.12K | |
| 09-Jan-23 9:42 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-23 | Sale | 2,970 | $28.44 | $84,466.80 | (< 1%) 999.47K to 996.5K | |
| 23-Aug-22 4:47 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Aug-22 | Sale | 2,253 | $33.22 | $74,844.70 | (< 1%) 1.0M to 999.47K | |
| 21-Jul-22 7:36 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Jul-22 | Option Exercise | 62,500 | $0.68 | $42,500.00 | 7% 939.22K to 1.0M | |
| 15-Feb-22 6:56 PM View: | Denali Therapeutics Inc. (DNLI) | 11-Feb-22 | Sale | 2,560 | $34.69 | $88,806.40 | (< 1%) 972.78K to 970.22K | |
| 11-Feb-22 5:20 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Feb-22 | Market Sale | 1,296 | $37.09 | $48,072.70 | (< 1%) 974.08K to 972.78K | (9%) |
| 07-Jan-22 6:06 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-22 | Market Sale | 2,225 | $44.75 | $99,568.80 | (< 1%) 976.3K to 974.08K | 2% |
| 05-Jan-22 7:03 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-22 | Grant | 31,000 | -- | -- | 3% 945.3K to 976.3K | |
| 23-Aug-21 8:24 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Aug-21 | Market Sale | 2,285 | $49.57 | $113,263.00 | (< 1%) 947.59K to 945.3K | 1% |
| 16-Mar-21 7:16 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Mar-21 | Market Sale (Planned) | 50,000 | $61.89 | $3,094,560.00 | (5%) 997.59K to 947.59K | (< 1%) |
| 18-Feb-21 6:12 PM View: | Denali Therapeutics Inc. (DNLI) | 16-Feb-21 | Market Sale (Planned) | 50,000 | $65.09 | $3,254,710.00 | (5%) 1.05M to 997.59K | 4% |
| 16-Feb-21 7:42 PM View: | Denali Therapeutics Inc. (DNLI) | 11-Feb-21 | Market Sale | 3,035 | $70.34 | $213,480.00 | (< 1%) 1.05M to 1.05M | 4% |
| 11-Feb-21 7:11 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Feb-21 | Market Option Sale | 1,448 | $74.68 | $108,135.00 | (< 1%) 964.43K to 962.98K | |
| 11-Feb-21 7:11 PM View: | Denali Therapeutics Inc. (DNLI) | 07-Feb-21 | Option Exercise | 4,250 | -- | -- | < 1% 960.18K to 964.43K | |
| 20-Jan-21 6:46 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Jan-21 | Market Sale (Planned) | 50,000 | $71.45 | $3,572,560.00 | (5%) 1.01M to 960.18K | (6%) |
| 24-Aug-20 8:37 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Aug-20 | Payment of Exercise | 1,954 | $32.87 | $64,228.00 | (< 1%) 1.01M to 1.01M | |
| 24-Aug-20 8:37 PM View: | Denali Therapeutics Inc. (DNLI) | 20-Aug-20 | Option Exercise Duplicate | 5,643 | -- | -- | < 1% 1.01M to 1.01M | |
| 01-Apr-20 6:19 PM View: | Denali Therapeutics Inc. (DNLI) | 30-Mar-20 | Market Sale | 1,428 | $19.48 | $27,817.40 | (< 1%) 1.01M to 1.01M | 2% |
| 22-Aug-19 7:48 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Aug-19 | Payment of Exercise | 1,977 | $18.59 | $36,745.30 | (< 1%) 1.01M to 1.0M | |
| 22-Aug-19 7:48 PM View: | Denali Therapeutics Inc. (DNLI) | 20-Aug-19 | Option Exercise | 5,643 | -- | -- | < 1% 1000.0K to 1.01M | |
| 12-Dec-17 5:38 PM View: | Denali Therapeutics Inc. (DNLI) | 12-Dec-17 | Conversion | 500,000 | -- | -- | 100% 500.0K to 1000.0K |